Michael J. Kaufman - Net Worth and Insider Trading
Michael J. Kaufman Net Worth
The estimated net worth of Michael J. Kaufman is at least $83,839 dollars as of 2024-11-10. Michael J. Kaufman is the Chief Manufacturing Officer of Mersana Therapeutics Inc and owns about 32,622 shares of Mersana Therapeutics Inc (MRSN) stock worth over $83,839. Details can be seen in Michael J. Kaufman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael J. Kaufman has not made any transactions after 2021-07-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael J. Kaufman
Michael J. Kaufman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael J. Kaufman owns 1 companies in total, including Mersana Therapeutics Inc (MRSN) .
Click here to see the complete history of Michael J. Kaufman’s form 4 insider trades.
Insider Ownership Summary of Michael J. Kaufman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRSN | Mersana Therapeutics Inc | 2021-07-19 | Sr VP Chmistry & Man & Control |
Michael J. Kaufman Latest Holdings Summary
Michael J. Kaufman currently owns a total of 1 stock. Michael J. Kaufman owns 32,622 shares of Mersana Therapeutics Inc (MRSN) as of July 19, 2021, with a value of $83,839.
Latest Holdings of Michael J. Kaufman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRSN | Mersana Therapeutics Inc | 2021-07-19 | 32,622 | 2.57 | 83,839 |
Holding Weightings of Michael J. Kaufman
Michael J. Kaufman Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael J. Kaufman has made a total of 1 transactions in Mersana Therapeutics Inc (MRSN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Mersana Therapeutics Inc is the sale of 12,088 shares on July 19, 2021, which brought Michael J. Kaufman around $147,957.
Insider Trading History of Michael J. Kaufman
- 1
Michael J. Kaufman Trading Performance
Michael J. Kaufman Ownership Network
Ownership Network List of Michael J. Kaufman
Ownership Network Relation of Michael J. Kaufman
Michael J. Kaufman Owned Company Details
What does Mersana Therapeutics Inc do?
Who are the key executives at Mersana Therapeutics Inc?
Michael J. Kaufman is the Sr VP Chmistry & Man & Control of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include SVP & Chief Development Officer Mohan Bala , Chief Legal Officer Alejandra Carvajal , and Sr. VP & Finance & Product stgy Brian Deschuytner .
Mersana Therapeutics Inc (MRSN) Insider Trades Summary
Over the past 18 months, Michael J. Kaufman made no insider transaction in Mersana Therapeutics Inc (MRSN). Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 20,914 shares made by Mohan Bala , a net sale of 24,096 shares made by Timothy B Lowinger , and a net sale of 23,014 shares made by Brian Deschuytner .
In summary, during the past 3 months, insiders sold 115,271 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 115,271 shares. During the past 18 months, 184,420 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 184,420 shares.
Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mersana Therapeutics Inc Insider Transactions
Michael J. Kaufman Mailing Address
Above is the net worth, insider trading, and ownership report for Michael J. Kaufman. You might contact Michael J. Kaufman via mailing address: 840 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
